SVP Clinical Development Jeffrey Wiezorek sold $75K of Kite Pharma, Inc.

Sold$75,000

$50.00Price

1,500Shares

−7%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Fri, Jan 6. Filed Tue, Jan 10, 12:04 PM ET, during the session. Not investment advice.